Palvella Therapeutics (PVLA) Current Leases (2021 - 2026)

Palvella Therapeutics (PVLA) has 5 years of Current Leases data on file, last reported at $209000.0 in Q1 2026.

• Quarterly Current Leases changed N/A year-over-year to $209000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $209000.0 (changed N/A YoY) and the FY2025 annual result came in at $202000.0, changed N/A from the prior year.
• Current Leases grew to $209000.0 in Q1 2026 per PVLA's latest filing, from $202000.0 in the prior quarter.
• Across five years, Current Leases topped out at $12.3 million in Q3 2023 and bottomed at $202000.0 in Q4 2025.
• The 4-year median for Current Leases is $859000.0 (2022), against an average of $2.3 million.
• The widest annual swing landed in 2022, when Current Leases slipped 18.11%; it then soared 1388.14% in 2023.
• Tracing PVLA's Current Leases over 4 years: stood at $859000.0 in 2022, then soared by 1330.97% to $12.3 million in 2023, then tumbled by 98.36% to $202000.0 in 2025, then rose by 3.47% to $209000.0 in 2026.
• Per Business Quant, the three latest PVLA Current Leases figures stand at $209000.0 (Q1 2026), $202000.0 (Q4 2025), and $12.3 million (Q3 2023).

Peer Comparison